South Korean Parliament Passes Law Banning Type Of Cloning, Broadening Embryonic Stem Cell Research
By Agence France-Presse,
Agence France-Presse
| 05. 20. 2008
South Korea's Parliament on Friday passed a law that bans inserting human somatic cells -- or cells that can form tissues and organs -- into animal eggs and allows researchers to use human embryonic stem cells to treat "general" diseases, Agence France-Presse reports. A previous law only allowed embryonic stem cells to be used for research to treat infertility and "rare or incurable" diseases, according to Agence France-Presse.
The ban on cross-species cloning is punishable by up to three years in jail, according to the country's Health Ministry. Kim Seung-Il, a health ministry official, said, "This law is aimed at enhancing bioethics." Park Se-Pill, a cloning expert, said the law "will serve as a very serious hindrance to research into cloning," adding that he and colleagues often used animal eggs in their research "because many eggs were needed while human eggs were difficult to obtain." Park said that South Korea is "going backward while other countries move ahead" with the research (Agence France-Presse, 5/16).
Related Articles
By Emily Baumgaertner Nunn, The New York Times | 06.30.2026
A research program at the National Institutes of Health released the world’s largest database of human genomes and paired them with clinical data, officials announced Tuesday, paving the way for a new era of study in personalized medicine.
The All...
By Sarah Norcross, Sandy Starr, Amanda Cooney, and Anneliese Burton, BioNews | 07.06.2026
By Mustapha Bature Sallama, Modern Ghana | 06.11.2026
In much of West Africa, a woman who cannot bear children does not merely face a medical condition. She faces a verdict. Her marriage may unravel. Her community may turn cold. Her identity, in a social order that ties womanhood...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...